益盛药业最新股东户数环比下降6.04% 筹码趋向集中

Core Viewpoint - Yisheng Pharmaceutical reported a decrease in the number of shareholders, indicating a potential decline in investor interest and confidence in the company [2] Shareholder Information - As of December 31, the number of shareholders was 23,534, a decrease of 1,513 from the previous period (December 20), representing a decline of 6.04% [2] - This marks the second consecutive period of decline in the number of shareholders [2] Stock Performance - The closing price of Yisheng Pharmaceutical was 7.70 yuan, reflecting an increase of 0.92% [2] - Since the concentration of shares began, the stock price has cumulatively decreased by 2.65%, with 4 days of increases and 5 days of decreases during the reporting period [2] Financial Performance - For the first three quarters, the company achieved a revenue of 476 million yuan, a year-on-year decrease of 5.81% [2] - The net profit for the same period was 24.12 million yuan, down 32.72% year-on-year [2] - The basic earnings per share were 0.0729 yuan, with a weighted average return on equity of 1.08% [2]